What is this product?
Enbrel is indicated for the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a tumor necrosis factor (TNF) blocker. Etanercept is an active ingredient. It is supplied as a solution for injection. This product was originally manufactured by Immunex Corporation. Currently, this product is manufactured by Amgen Inc. due to the acquisition of Immunex by Amgen.
What is it made of?
Enbrel is a clear and colorless, sterile, preservative-free solution. Enbrel’s active ingredient is etanercept. It is a TNF blocker which is a dimeric fusion protein consisting of the extracellular ligand-binding portion of the tumor necrosis factor receptor. Enbrel is produced by recombinant deoxyribonucleic acid (DNA) technology.